Evidence map›Paper›PMID 36174236›Full record

ArticleGut microbes

Quantitative insights into effects of intrapartum antibiotics and birth mode on infant gut microbiota in relation to well-being during the first year of life.

Roosa Jokela, Katri Korpela, Ching Jian, Evgenia Dikareva, Anne Nikkonen, Terhi Saisto, Kirsi Skogberg, Willem M de Vos, Kaija-Leena Kolho, Anne Salonen

Open access · goldAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Systematic evaluation of metatranscriptomic differential gene expressionbioRxiv : the preprint server for biology · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Persistent reduction ofFrontiers in immunology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Roosa JokelaHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Katri KorpelaHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Ching JianHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Evgenia DikarevaHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Anne NikkonenChildren's Hospital, Pediatric Research Center, University of Helsinki, Helsinki, Finland.
Terhi SaistoDepartment of Obstetrics and Gynecology, University of Helsinki, and Helsinki University Hospital, Helsinki, Finland.
Kirsi SkogbergClinic of Infectious Diseases, Jorvi and Helsinki University Hospital, Helsinki, Finland.
Willem M de VosHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Kaija-Leena KolhoChildren's Hospital, Pediatric Research Center, University of Helsinki, Helsinki, Finland.
Anne SalonenHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-6960-7447
University of Helsinki · FIHelsinki University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Birth mode and maternal intrapartum (IP) antibiotics affect infants' gut microbiota development, but their relative contribution to absolute bacterial abundances and infant health has not been studied. We compared the effects of Cesarean section (CS) delivery and IP antibiotics on infant gut microbiota development and well-being over the first year. We focused on 92 healthy infants born between gestational weeks 37-42 vaginally without antibiotics (N = 26), with IP penicillin (N = 13) or cephalosporin (N = 7) or by CS with IP cephalosporin (N = 33) or other antibiotics (N = 13). Composition and temporal development analysis of the gut microbiota concentrated on 5 time points during the first year of life using 16S rRNA gene amplicon sequencing, integrated with qPCR to obtain absolute abundance estimates. A mediation analysis was carried out to identify taxa linked to gastrointestinal function and discomfort (crying, defecation frequency, and signs of gastrointestinal symptoms), and birth interventions. Based on absolute abundance estimates, the depletion of

Indexed as

Gastrointestinal MicrobiomeAnti-Bacterial AgentsCephalosporinsCesarean SectionFemaleHumansInfantMonobactamsPenicillinsPregnancyRNA, Ribosomal, 16SAnti-Bacterial AgentsCephalosporinsMonobactamspenicillin NPenicillinsRNA, Ribosomal, 16S16S rRNA gene amplicon sequencingantibioticsbirth routecesarean sectionEarly-life microbiotaquantitative microbiota profiling

Identifiers

PMID36174236
PMCPMC9542534
OpenAlexW4297961915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.